Glecaprevir/pibrentasvir
id:
glecaprevir-pibrentasvir-260-17733750
title:
Glecaprevir/pibrentasvir
text:
Glecaprevir/pibrentasvir (G/P), sold under the brand names Mavyret and Maviret, is a fixed-dose combination medication used to treat hepatitis C. It contains glecaprevir and pibrentasvir. It works against all six types of hepatitis C. At twelve weeks following treatment between 81% and 100% of people have no evidence of hepatitis C. It is taken once a day by mouth with food. The most common side effects are headache, diarrhea, and tiredness. In those with a history of hepatitis B, reactivation m
brand slug:
wiki
category slug:
encyclopedia
description:
Combination drug
original url:
https://en.wikipedia.org/wiki/Glecaprevir/pibrentasvir
date created:
date modified:
2024-04-14T03:38:39Z
main entity:
{"identifier":"Q39048038","url":"https://www.wikidata.org/entity/Q39048038"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/2/2e/Glecaprevir_and_pibrentasvir.svg","width":657,"height":306}
fields total:
13
integrity:
15